The global ophthalmology drugs and devices market is expected to see significant growth over the next five years or so, according to a report by Research and Markets.
Here are four trends:
1. The market is expected to grow at a compound annual growth rate of 7 percent.
2. The market is driven by various factors, including the increase in eye-related disorders and regulatory approvals to new drugs and devices.
3. However, factors such as expiration of patents, drying pipelines and major slowdowns in economies may hinder the market growth.
4. Top players in the market include Abbot Laboratories, Johnson & Johnson, Alcon, Allergan and Bausch & Lomb.